Peptide therapy uses short chains of amino acids that act like the body’s own signaling molecules to support areas like metabolism, tissue repair, and hormone balance. Some peptides are FDA-approved medications; many others are not, and a few are currently restricted or under FDA review for pharmacy compounding. Because peptide use is individualized and regulatory status varies, it should always be guided by a prescribing physician and a licensed compounding pharmacy.
If you have spent any time researching hormone health, recovery, or weight management lately, you have probably come across the term peptide therapy. Maybe a friend mentioned it, or you saw it discussed online and wondered if it applies to you. It is a reasonable question and also a more complicated one than most headlines suggest.
Peptides are not new. Your body has been using them as chemical messengers your whole life. What is newer is the growing interest in using specific peptides as part of a treatment plan, and the regulatory landscape around that use is evolving quickly, including changes that took place earlier this year. This article covers what peptides are, how they work, where the science and regulations currently stand, and what questions to ask your physician before considering this option. Nothing here is a recommendation to use any particular peptide.
What Is Peptide Therapy?
Peptide therapy is the medical use of peptides, which are short chains of amino acids, to encourage a specific effect in the body.
Amino acids are the building blocks of proteins. When a small number of them link together, they form a peptide; when the chain grows much longer and folds into a complex structure, it becomes a protein. Peptides are essentially smaller, simpler versions of the molecules your cells already use to communicate.
This is not a foreign concept to your biology. Many hormones, including insulin, are peptides. Growth factors and other signaling molecules that regulate everything from appetite to wound healing are peptides too, as described in a research review on therapeutic peptides published in Nature’s Signal Transduction and Targeted Therapy. Peptide therapy borrows from that natural system, using peptides that are manufactured and prescribed to support a specific biological function.
How Do Therapeutic Peptides Work in the Body?
Therapeutic peptides work by binding to specific receptors on cells, similar to how many of your body’s own hormones deliver instructions.
Think of a receptor as a lock and a peptide as a key shaped to fit it. When the peptide binds, it triggers a chain of events inside the cell, prompting it to do something specific, such as release a hormone, reduce inflammation, or support tissue repair. This is a more targeted mechanism than many small-molecule pills, which often act more broadly throughout the body, as outlined in the same Nature review of peptide pharmacology.
That targeted, protein-like structure is also why many peptides cannot simply be swallowed. Digestive enzymes are built to break down amino acid chains, which means an oral peptide can lose its effectiveness before it ever reaches the bloodstream. This is part of why many therapeutic peptides are prepared as injectable formulations, and it is one reason sterile, precise compounding matters so much for this category of medication.
Common Categories of Therapeutic Peptide Use
Researchers and physicians study peptides across several broad categories. Being studied, or even used clinically in some cases, does not mean every peptide in a category is FDA-approved or right for a given patient.
- Metabolic and weight-related support. This is the category most people recognize, largely because of GLP-1 receptor agonists, a class of peptides that does include FDA-approved medications. Other peptides studied for metabolic effects remain investigational.
- Tissue repair and recovery support. Some peptides are studied for their potential role in supporting the body’s natural repair processes, an area of active research interest.
- Immune modulation. Certain peptides are being explored for their influence on immune system signaling.
- Hormone-related support. Peptides that interact with the endocrine system are studied for their potential role in hormone regulation, an area connected to the kind of care discussed on our Men’s Health and Women’s Health pages.
A position statement from the Obesity Medicine Association, available through NIH’s PubMed Central, underscores this distinction clearly: some peptides in these categories have gone through the FDA approval process, and many others have not. That difference matters a great deal when it comes to safety data, manufacturing standards, and appropriate use.
Is Peptide Therapy FDA-Approved?
The honest answer is that it depends on the specific peptide. Some peptides are FDA-approved drugs. Many peptides used in wellness or functional-medicine settings are not FDA-approved. A smaller subset is formally restricted from pharmacy compounding altogether.
To understand why, it helps to know how compounding pharmacies are allowed to use bulk ingredients in the first place. Under Section 503A of the Food, Drug, and Cosmetic Act, a pharmacy can generally compound with a substance if it meets a United States Pharmacopeia (USP) monograph, is a component of an FDA-approved drug, or appears on the FDA’s official list of approved 503A bulk substances, as explained on the FDA’s bulk drug substances page, are substances that do not fit any of those pathways and are evaluated under an interim policy that sorts them into categories, generally described as Category 1 (compounding may continue while under review), Category 2 (compounding is discouraged pending review because of identified safety concerns), and Category 3 (compounding is not appropriate). The FDA maintains details on ingredients it has flagged for potential safety risk on its Category 2 substances page.
“Not every peptide on the market has FDA approval, which is exactly why a prescriber’s guidance matters.”
What Changed in 2026
This is an area that has moved quickly this year, and it is worth understanding where things stand as of this writing.
In April 2026, the FDA removed twelve peptides from its Category 2 list, a step that reflected updated agency review of those specific substances, as detailed on the FDA’s 503A bulk substances resources.
Then, on July 23 and 24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) held a public meeting to review seven peptides being considered for the 503A bulks list: BPC-157, KPV, TB-500, MOTS-c, Emideltide (also known as DSIP), Semax, and Epitalon, according to the FDA’s meeting page for the July 2026 PCAC session. Coverage from Healio reported that the committee recommended six of the seven peptides for possible addition to the 503A bulks list.
It is important to understand what that recommendation does and does not mean. A PCAC vote is advisory and nonbinding. The FDA has not issued a final rule adopting these recommendations as of this writing, and the regulatory status of these specific peptides can still change. This article does not name any peptide here as a suggestion to use it; it is simply describing the current state of federal review so you have accurate context for a conversation with your physician.
Why Are Compounding Pharmacies Involved in Peptide Dispensing?
Compounding pharmacies play a role in peptide dispensing because many peptides are not mass-produced by commercial manufacturers in standardized, one-size-fits-all doses the way many traditional prescription drugs are.
A licensed compounding pharmacy prepares individualized, prescription-based formulations under sterile USP <797> standards designed specifically for injectable and other sterile preparations. That level of precision matters, because peptides are sensitive molecules that need careful handling, accurate measurement, and a controlled environment to remain stable and safe.
This process exists to fill a gap: patients whose clinical needs are not met by a standardized commercial product may, with a valid prescription from their physician, have a formulation tailored to them. Resources from compounding organizations such as PCCA and the NIH-hosted Obesity Medicine Association statement both emphasize that this kind of individualized preparation always requires a valid prescription and physician oversight, which is also central to how our Functional Medicine program works with prescribers.
What to Ask Your Doctor Before Considering Peptide Therapy
Because the science and the regulatory status of peptides vary so widely, the right first step is always a conversation with your prescribing physician, not a decision made from an article or an advertisement.
A few questions worth bringing to that conversation:
– What is the current FDA and regulatory status of the specific peptide we are discussing?
– Is this an appropriate option given my full health history, current medications, and any conditions I have?
– How would my response be monitored, and what would follow-up look like?
– Are there FDA-approved alternatives that address the same concern?
This article is meant to help you ask better questions, not to recommend that you pursue peptide therapy. If you would like to talk through options with a licensed provider connected to our Functional Medicine team, our pharmacists are also available through our Contact page.
Finding a Trusted Source for Compounded Peptide Therapy
A legitimate, prescription-based compounding pharmacy should be easy to identify by a few consistent markers.
It should follow sterile compounding standards for any injectable preparation. It should be staffed by licensed pharmacists who can answer detailed questions about a formulation. It should never dispense a compounded peptide without a valid prescription from a physician. It should also be transparent about the FDA status of the ingredients it works with, rather than glossing over that detail.
A licensed compounding pharmacy fills prescriptions, it doesn’t replace the physician who writes them.
At King’s Pharmacy and Compounding Center in Irvine, this is the role we play: a compounding partner that works alongside your prescriber, not a substitute for their care. If your physician has discussed a compounded formulation with you, our team can help answer questions about the preparation process and work directly with your provider’s office. You can reach us through our Contact page or manage an existing prescription through our Refill page.
Conclusion
Peptide therapy sits at an interesting intersection of established biology and fast-moving regulation. Peptides themselves are not exotic; your body relies on them constantly, but the FDA status of any specific peptide can vary widely, and 2026 has already brought meaningful regulatory changes worth knowing about. The most important takeaway is this: whether a peptide is appropriate for you is a decision that belongs with your physician, informed by your health history and the current regulatory picture, not a generic recommendation.
Have questions about whether a compounded medication is right for you? Talk to your prescribing physician, then connect with the pharmacists at King’s Pharmacy and Compounding Center in Irvine, CA, to get started.
Request a Refill or Contact King’s Pharmacy at 949.387.0780.
Frequently Asked Questions
Is peptide therapy FDA-approved?
It depends on the specific peptide. Some peptides, such as certain GLP-1 receptor agonists, are FDA-approved medications. Many peptides used in wellness or functional-medicine settings are not FDA-approved, and a subset is currently restricted from compounding while under FDA review. Your physician and pharmacist can help clarify the status of a specific peptide.
Do I need a prescription to get compounded peptide therapy?
Yes. A licensed compounding pharmacy can only prepare a peptide formulation with a valid prescription from a physician who has evaluated your health history and determined it is appropriate for you.
Are all peptides injectable?
Not all, but many are. Because peptides are amino acid chains, they can break down in the digestive system before reaching the bloodstream, which is why injectable and other specialized delivery forms are common for this category of medication.
What changed with FDA rules on peptides in 2026?
In April 2026, the FDA removed twelve peptides from its Category 2 list. In July 2026, an FDA advisory committee reviewed seven additional peptides and recommended six for possible addition to the approved compounding substances list, though that recommendation is nonbinding and the FDA has not issued a final rule as of this writing.
How do I know if a compounding pharmacy is legitimate?
Look for sterile compounding standards, licensed pharmacists on staff, a strict requirement for a valid prescription, and transparency about the FDA status of the ingredients used in any formulation.
